Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million

Annual General Meeting, Investor News 2024-11-15
STOCKHOLM – November 15, 2024 – reference is made to the stock exchange announcement made by Inify Laboratories AB (“Inify” or the “Company”) on 23 October 2024 regarding expansion to the UK and a potential share issue of approximately SEK 150 million. The Company will in a separate press release call for an Extraordinary General […]
Read More

Inify Laboratories – notice of Extraordinary General Meeting on December 6, 2024

Annual General Meeting, Investor News 2024-11-15
Stockholm – November 15, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Extraordinary General Meeting on December 6, 2024. Please find attached the invitation including attachment, agenda and details on how to register and vote. The invitation is also available on the […]
Read More

Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer

Investor News, News 2024-11-05
STOCKHOLM – November 05, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, is proud to announce a partnership with the ProMort research team at Karolinska Institutet, aimed at transforming prostate cancer diagnostics. The primary objective of this collaboration is to improve the precision of prostate cancer diagnosis through AI-driven […]
Read More

Panel talk about Inify’s third quarter 2024

Investor News 2024-10-25
Inify Laboratories have decided to establish its operation to the United Kingdom and expand diagnostics to the gastrointestinal field. One of the major challenges in the UK is long and unpredictable response times and varying quality in prostate cancer care. The market is six times larger than Sweden´s in terms of patient volume, with approximately […]
Read More

Inify Laboratories: Establishment in the United Kingdom and expansion into gastrointestinal diagnostics

Financial reports, Investor News 2024-10-23
STOCKHOLM – October 23, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has after extensive market mapping decided to establish operations in the United Kingdom (UK).   “After our successful launch in Sweden, where we now have around 80% of the Stockholm market share, the time is right to […]
Read More

Panel talk about Inify’s second quarter 2024

Investor News 2024-09-09
Inify Laboratories continued to deliver strong growth with sales of SEK 3.6 million in the quarter – up 62% compared to Q1. By the end of June, the laboratory had been open for over a year and had diagnosed more than 1,000 patients. More details about the laboratory operations and its success factors are discussed […]
Read More